These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 7021694
21. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients. Emanuelli G, Gatti G, Calcamuggi G, Anfossi G, Cotto A, Marcarino C, Camussi G, Ottone G. Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894 [No Abstract] [Full Text] [Related]
22. [Changes of insulin antibody binding ability during monocomponent insulin therapy]. Araki S, Sasai T, Shichiri M, Yoshikawa R, Hoshi M. Horumon To Rinsho; 1977 Jan; 25(1):55-60. PubMed ID: 557390 [No Abstract] [Full Text] [Related]
23. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment]. Bruni B, Turco GL. Minerva Med; 1973 Nov 10; 64(80):4224-31. PubMed ID: 4765430 [No Abstract] [Full Text] [Related]
24. [Detection of insulin-neutralizing antibodies using I-125-bound insulin]. Láng I, Stützel M, Littmann L, Balázsi I. Orv Hetil; 1974 Jan 27; 115(4):211-2. PubMed ID: 4839803 [No Abstract] [Full Text] [Related]
25. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations]. Göbel P, Kramer W, Heni F. Verh Dtsch Ges Inn Med; 1974 Jan 27; 83():1426-9. PubMed ID: 611859 [No Abstract] [Full Text] [Related]
26. [The use of human insulin in 3 patients with diabetes mellitus and insulin resistance]. Khristov V, Manov A. Vutr Boles; 1989 Jan 27; 28(1):51-6. PubMed ID: 2662609 [Abstract] [Full Text] [Related]
27. Behaviour of insulin antibodies in diabetics treated with different insulins. Mincu I, Cheţa D, Ionescu-Tîrgovişte C, Mirodon Z, Sîntu E. Med Interne; 1980 Jan 27; 18(4):347-52. PubMed ID: 7006044 [Abstract] [Full Text] [Related]
28. Immunobiological studies in two cases of insulin-resistant diabetes. de Assis LM, Nicolau W, Salomon JB, de Cintra AB, Pieroni RR. AMB Rev Assoc Med Bras; 1970 Jan 27; 16(1):5-18. PubMed ID: 5311115 [No Abstract] [Full Text] [Related]
29. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G, Borkenstein M, Fink M, Mayr WR, Menzel J, Schober E. Diabetes Care; 1983 Jan 27; 6 Suppl 1():43-8. PubMed ID: 6343038 [Abstract] [Full Text] [Related]
31. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications. Andreani D, Iavicoli M, Tamburrano G, Menzinger G, Maltarello C. Horm Metab Res; 1974 Nov 27; 6(6):447-54. PubMed ID: 4476720 [No Abstract] [Full Text] [Related]
32. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]. Iavicoli M, Di Mario U, Coronel GA, Musacchio N, Arduini P. Minerva Endocrinol; 1984 Nov 27; 9(2):115-20. PubMed ID: 6390124 [No Abstract] [Full Text] [Related]
38. Insulin antibodies and the control of diabetes. Dixon K, Exon PD, Malins JM. Q J Med; 1975 Oct 03; 44(176):543-53. PubMed ID: 1105646 [Abstract] [Full Text] [Related]
39. [The appearance of insulin antibodies in diabetics]. Tomasević M, Galić A, Radec V. Med Arh; 1987 Oct 03; 41(6):331-3. PubMed ID: 3270735 [No Abstract] [Full Text] [Related]
40. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics. Irvine WJ, Al-Khateeb SF, Di Mario U, Feek CM, Gray RS, Edmond B, Duncan LJ. Clin Exp Immunol; 1977 Oct 03; 30(1):16-21. PubMed ID: 606435 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]